Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparisons and correlations of 1-month recall vs 24-hour recall in patient-reported outcomes of an exploratory, phase 2b, randomized, double-blind, placebo-controlled clinical trial of sildenafil cream, 3.6% for the treatment of female sexual arousal disorder.
Johnson I, Thurman AR, Cornell KA, Symonds T, Hatheway J, Friend DR, Goldstein A. Johnson I, et al. Among authors: thurman ar. J Sex Med. 2024 Sep 3;21(9):787-792. doi: 10.1093/jsxmed/qdae086. J Sex Med. 2024. PMID: 39059373 Clinical Trial.
A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women.
Thurman A, Hull ML, Stuckey B, Hatheway J, Zack N, Mauck C, Friend D. Thurman A, et al. Menopause. 2023 Aug 1;30(8):817-823. doi: 10.1097/GME.0000000000002210. Epub 2023 Jun 20. Menopause. 2023. PMID: 37339390 Free PMC article. Clinical Trial.
A phase 1/2, open-label, parallel group study to evaluate the preliminary efficacy and usability DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal RinGSM) over 12 weeks in healthy postmenopausal women.
Thurman A, Hull ML, Stuckey B, Hatheway J, Zack N, Mauck C, Friend D. Thurman A, et al. Menopause. 2023 Sep 1;30(9):940-946. doi: 10.1097/GME.0000000000002230. Epub 2023 Aug 7. Menopause. 2023. PMID: 37625088 Free PMC article. Clinical Trial.
72 results